96929-05-4 (乙基2-(叔丁氧羰基(甲基)氨基)噻唑-4-甲酸酯,ethyl 2-({[(tert-butoxy)carbonyl]amino}methyl)-1,3-thiazole-4-carboxylate)

CAS号:
96929-05-4
中文名称:
乙基2-(叔丁氧羰基(甲基)氨基)噻唑-4-甲酸酯
英文名称:
ethyl 2-({[(tert-butoxy)carbonyl]amino}methyl)-1,3-thiazole-4-carboxylate
分子式:
C12H18N2O4S
分子量:
286.347321987152

乙基2-(叔丁氧羰基(甲基)氨基)噻唑-4-甲酸酯(96929-05-4)名称与标识符

名称

中文别名:
2-((叔丁氧羰基氨基)甲基)噻唑-4-甲酸乙酯;2-((叔丁氧基羰基氨基)甲基)噻唑-4-羧酸乙酯;乙基2-(叔丁氧羰基(甲基)氨基)噻唑-4-甲酸酯;
英文别名:
Ethyl 2-(Boc-aminomethyl)thiazole-4-carboxylate;Ethyl 2-(((tert-butoxycarbonyl)amino)methyl)thiazole-4-carboxylate;Ethyl 2-((tert-butoxycarbonyl)-methyl)thiazole-4-carboxylate;ethyl 2-((tert-butoxycarbonylamino)methyl)thiazole-4-carboxylate;ethyl 2-[[(2-methylpropan-2-yl)oxycarbonylamino]methyl]-1,3-thiazole-4-carboxylate;tert-butyl (4-(ethoxycarbonyl)thiazol-2-yl)methylcarbamate;1-(tert-butoxycarbonyl)amino-1-(4-carboethoxythiazol-2-yl)methane;2-(N-tert-Butyloxycarbonylaminomethyl)-4-ethoxycarbonylthiazole;Boc-Gly-Cys(Thz)-OEt;ethyl 2-(N-t-butoxycarbonylamino)methylthiazol-4-carboxylate;ethyl 2-[N-(tert-butoxycarbonyl)aminomethyl]thiazole-4-c;ethyl 2-({[(tert-butoxy)carbonyl]amino}methyl)-1,3-thiazole-4-carboxylate;2-(TERT-BUTOXYCARBONYLAMINO-METHYL)-THIAZOLE-4-CARBOXYLIC ACID ETHYL ESTER;PubChem17857;IIBLNWWFRAOZDR-UHFFFAOYSA-N;Ethyl 2-[[[(1,1-dimethylethoxy)carbonyl]amino]methyl]-4-thiazolecarboxylate (ACI);Ethyl 2-((tert-butoxycarbonyl)methyl)thiazole-4-carboxylate;ethyl 2-{[(tert-butoxycarbonyl)amino]methyl}-1,3-thiazole-4-carboxylate;DTXSID90432932;DS-10967;J-520565;96929-05-4;C12H18N2O4S;EN300-132092;SY006817;AB53961;AKOS015920359;CHEMBL3221668;SCHEMBL7145374;DB-080441;ETHYL2-(((TERT-BUTOXYCARBONYL)AMINO)METHYL)THIAZOLE-4-CARBOXYLATE;CS-W022640;ethyl 2-(tert-butoxycarbonylamino)methylthiazole-4-carboxylate;MFCD09878704;

标识符

MDL:
MFCD09878704
InChIKey:
IIBLNWWFRAOZDR-UHFFFAOYSA-N
Inchi:
1S/C12H18N2O4S/c1-5-17-10(15)8-7-19-9(14-8)6-13-11(16)18-12(2,3)4/h7H,5-6H2,1-4H3,(H,13,16)
SMILES:
O=C(NCC1SC=C(C(OCC)=O)N=1)OC(C)(C)C

乙基2-(叔丁氧羰基(甲基)氨基)噻唑-4-甲酸酯(96929-05-4)物化性质

实验特性

  • LogP : 2.73540
  • PSA : 105.76000
  • 折射率 : 1.522
  • 沸点 : 401.4±25.0 °C at 760 mmHg
  • 熔点 : No data available
  • 蒸气压 : 0.0±0.9 mmHg at 25°C
  • 闪点 : 196.5±23.2 °C
  • 颜色与性状 : No data avaiable
  • 密度 : 1.2±0.1 g/cm3

计算特性

  • 精确分子量 : 286.09900
  • 氢键供体数量 : 1
  • 氢键受体数量 : 6
  • 可旋转化学键数量 : 7
  • 同位素质量 : 286.09872823g/mol
  • 重原子数量 : 19
  • 复杂度 : 330
  • 同位素原子数量 : 0
  • 确定原子立构中心数量 : 0
  • 不确定原子立构中心数量 : 0
  • 确定化学键立构中心数量 : 0
  • 不确定化学键立构中心数量 : 0
  • 共价键单元数量 : 1
  • 疏水参数计算参考值(XlogP) : 2
  • 拓扑分子极性表面积 : 106

乙基2-(叔丁氧羰基(甲基)氨基)噻唑-4-甲酸酯(96929-05-4)海关数据

海关编码:
2934100090
海关数据:

中国海关编码:

2934100090

概述:

2934100090. 结构上含有一个非稠合噻唑环的化合物(不论是否氢化). 增值税率:17.0%. 退税率:9.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0%

申报要素:

品名, 成分含量, 用途

Summary:

2934100090 other compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:20.0%

乙基2-(叔丁氧羰基(甲基)氨基)噻唑-4-甲酸酯(96929-05-4)推荐厂家 更多厂家(25)

公司名称手机号/电话联系人QQ微信询单
西安德而塔生物科技有限公司 18133906270
18133906270
张女士 2590956145
询单
上海瀚思化工有限公司 18939883912
021-34536277
顾经理 3003949364
询单
上海绩祥生物科技有限公司 13093077543陆经理 3985448220
询单
铼博(上海)生化科技有限公司 13311756052
021-60536361 13311756052 13311756131
张经理 2851717387
询单
上海一基实业有限公司 13311756131
021-60548336 QQ:2355265332 QQ:2851717387
胡经理 2355265332
询单
上海一基实业有限公司 13311756052
021-60526763 13311756052 13311756131
胡经理 2355265332
询单
南通众合化工新材料有限公司 18762756250
0513-55074056
胡经理 2369399482
询单
赫澎(上海)生物科技有限公司 13122891558
186-16545970
张硕 3418426269
询单
赫澎(上海)生物科技有限公司 13122891558
186-16545970
张硕 3418426269
询单
上海腾准生物科技有限公司 19821570922
021-34053661
张经理 3003871136
询单

乙基2-(叔丁氧羰基(甲基)氨基)噻唑-4-甲酸酯(96929-05-4)合成路线

合成路线:1 步
反应条件:
参考文献:
Biological evaluation of new largazole analogues: Alteration of macrocyclic scaffold with Click chemistry
Li, Xianlin; Tu, Zhenchao; Li, Hua; Liu, Chunping; Li, Zheng; et al, ACS Medicinal Chemistry Letters, 2013, 4(1), 132-136
合成路线:1 步
反应条件:
参考文献:
Synthesis, structure-activity analysis, and biological evaluation of sanguinamide B analogues
Wahyudi, Hendra; Tantisantisom, Worawan; Liu, Xuechao; Ramsey, Deborah M.; Singh, Erinprit K.; et al, Journal of Organic Chemistry, 2012, 77(23), 10596-10616
合成路线:1 步
反应条件:
参考文献:
Depsipeptide analogs of the antitumor drug distamycin containing thiazole amino acid residues
Bailly, Christian; Houssin, Raymond; Bernier, Jean Luc; Henichart, Jean Pierre, Tetrahedron, 1988, 44(18), 5833-43
合成路线:1 步
反应条件:
参考文献:
Total synthesis of largazole
Ren, Qi; Dai, Lu; Zhang, Hui; Tan, Wenfei; Xu, Zhengshuang; et al, Synlett, 2008, (15), 2379-2383
合成路线:1 步
反应条件:
参考文献:
Synthesis of the molecular hybrid inspired by Largazole and Psammaplin A
Yu, Xiaoling; Zhang, Bingbing; Shan, Guangsheng; Wu, Yue; Yang, Feng-Ling; et al, Tetrahedron, 2018, 74(5), 549-555
合成路线:1 步
反应条件:
参考文献:
Synthesis and biological activity of largazole and derivatives
Seiser, Tobias; Kamena, Faustin; Cramer, Nicolai, Angewandte Chemie, 2008, 47(34), 6483-6485
合成路线:1 步
反应条件:
参考文献:
Process development and scale-up total synthesis of largazole, a potent class I histone deacetylase inhibitor
Chen, Qi-Yin; Chaturvedi, Pravin R.; Luesch, Hendrik, Organic Process Research & Development, 2018, 22(2), 190-199
合成路线:1 步
反应条件:
参考文献:
Convergent and Modular Synthesis of Candidate Precolibactins. Structural Revision of Precolibactin A
Healy, Alan R.; Vizcaino, Maria I.; Crawford, Jason M.; Herzon, Seth B., Journal of the American Chemical Society, 2016, 138(16), 5426-5432
合成路线:1 步
反应条件:
参考文献:
CP0569, A New Broad-Spectrum Injectable Carbapenem. Part 1: Synthesis and Structure-Activity Relationships
Aihara, Kazuhiro; Kano, Yuko; Shiokawa, Sohjiro; Sasaki, Toshiro; Setsu, Fumihito; et al, Bioorganic & Medicinal Chemistry, 2003, 11(16), 3475-3485
合成路线:1 步
反应条件:
参考文献:
RITA Mimics: Synthesis and Mechanistic Evaluation of Asymmetric Linked Trithiazoles
Pietkiewicz, Adrian L.; Zhang, Yuqi; Rahimi, Marwa N.; Stramandinoli, Michael; Teusner, Matthew; et al, ACS Medicinal Chemistry Letters, 2017, 8(4), 401-406
合成路线:1 步
反应条件:
参考文献:
Concise total synthesis of largazole
Xiao, Qiong; Wang, Li-Ping; Jiao, Xiao-Zhen; Liu, Xiao-Yu; Wu, Qian; et al, Journal of Asian Natural Products Research, 2010, 12(11-12), 940-949
合成路线:1 步
反应条件:
参考文献:
Studies on synthesis of amino acid derived thiazoles. Preparation of bis-thiazoles as key fragments of aerucyclamide analogs
Fagundez, Catherine; Serra, Gloria, Heterocyclic Letters, 2013, 3(4), 415-426
合成路线:1 步
反应条件:
参考文献:
Radical-Mediated Thiol-Ene Strategy: Photoactivation of Thiol-Containing Drugs in Cancer Cells
Sun, Shuang; Oliveira, Bruno L.; Jimenez-Oses, Gonzalo; Bernardes, Goncalo J. L., Angewandte Chemie, 2018, 57(48), 15832-15835
合成路线:1 步
反应条件:
参考文献:
Synthesis of a Microcystis aeruginosa predicted metabolite with antimalarial activity
Pena, Stella; Scarone, Laura; Manta, Eduardo; Stewart, Lindsay; Yardley, Vanessa; et al, Bioorganic & Medicinal Chemistry Letters, 2012, 22(15), 4994-4997
合成路线:1 步
反应条件:
参考文献:
Total synthesis of (+)-nostocyclamide
Moody, Christopher J.; Bagley, Mark C., Journal of the Chemical Society, 1998, (1998), 601-607
合成路线:1 步
反应条件:
参考文献:
Total synthesis of (+)-nostocyclamide
Moody, Christopher J.; Bagley, Mark C., Synlett, 1996, (12), 1171-1172
合成路线:1 步
反应条件:
参考文献:
Synthesis of cyclohexapeptides as antimalarial and anti-trypanosomal agents
Pena, S.; Fagundez, C.; Medeiros, A.; Comini, M.; Scarone, L.; et al, MedChemComm, 2014, 5(9), 1309-1316
合成路线:1 步
反应条件:
参考文献:
Total Synthesis of Microcin B17 via a Fragment Condensation Approach
Thompson, Robert E.; Jolliffe, Katrina A.; Payne, Richard J., Organic Letters, 2011, 13(4), 680-683
合成路线:1 步
反应条件:
参考文献:
Utilization of Alternate Substrates by the First Three Modules of the Epothilone Synthetase Assembly Line
Schneider, Tanya L.; Walsh, Christopher T.; O'Connor, Sarah E., Journal of the American Chemical Society, 2002, 124(38), 11272-11273
合成路线:1 步
反应条件:
参考文献:
Comprehensive Synthesis of Amino Acid-Derived Thiazole Peptidomimetic Analogues to Understand the Enigmatic Drug/Substrate-Binding Site of P-Glycoprotein
Patel, Bhargav A.; Abel, Biebele; Barbuti, Anna Maria; Velagapudi, Uday Kiran; Chen, Zhe-Sheng; et al, Journal of Medicinal Chemistry, 2018, 61(3), 834-864
合成路线:1 步
反应条件:
参考文献:
Discovery of Novel Class I Histone Deacetylase Inhibitors with Promising in Vitro and in Vivo Antitumor Activities
Yao, Yiwu; Tu, Zhengchao; Liao, Chenzhong; Wang, Zhen; Li, Shang; et al, Journal of Medicinal Chemistry, 2015, 58(19), 7672-7680
合成路线:1 步
参考文献:
Product class 17: thiazoles
Kikelj, D.; Urleb, U., Science of Synthesis, 2002, 11, 627-833
合成路线:1 步
反应条件:
参考文献:
Analog of dolastatin 3. Synthesis, proton NMR studies, and spatial conformation
Bernier, Jean Luc; Houssin, Raymond; Henichart, Jean Pierre, Tetrahedron, 1986, 42(10), 2695-702
合成路线:1 步
反应条件:
参考文献:
A convenient method for the preparation of 2-(1-aminoalkyl)thiazole-4-carboxylic acids, key intermediates in the total synthesis of naturally occurring antitumor cyclopeptides
Houssin, Raymond; Lohez, Michele; Bernier, Jean Luc; Henichart, Jean Pierre, Journal of Organic Chemistry, 1985, 50(15), 2787-8
合成路线:1 步
参考文献:
Dehydrooligopeptides. XIV. Syntheses of 2-[(Z)-1-aminoalken-1-yl]oxazole-4-carboxylic acid and the main common skeleton of thiostrepton peptide antibiotics A10255G and A10255J.
Okumura, Kazuro; Ito, Akio; Saito, Hiroyuki; Nakamura, Yutaka; Shin, Chung-gi, Bulletin of the Chemical Society of Japan, 1996, 69(8), 2309-2316

乙基2-(叔丁氧羰基(甲基)氨基)噻唑-4-甲酸酯(96929-05-4)参考资料

Beilstein:
E196123
PubChem CID: